Phase II study to topotecan and cisplatin in advanced hepatocellular carcinoma.

The Korean journal of internal medicine

Volumn 18, Issue 2, 2003, Pages 104-108

  Lee, Ga Young ^a   Kim, Bong Seog ^a   Seo, Yeoung Tae ^a   Choi, Seong Ho ^a   Kim, Hye Jin ^a   Choi, Dong Seog ^a   Ko, Ji Young ^a   Yang, Soo Hyun ^a   Byun, Jong Hoon ^a  

^a Seoul Veterans Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; TOPOTECAN;

AGED; ARTICLE; CLINICAL TRIAL; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TOPOTECAN; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 0042786574     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2003.18.2.104     Document Type: Article

References (0)